Khalid Muhammad
Khalid Muhammad
Assistant Professor-Immunology, United Arab Emirates University, UAE
Verified email at - Homepage
Cited by
Cited by
In vivo effects of the anti–interleukin‐6 receptor inhibitor tocilizumab on the B cell compartment
P Roll, K Muhammad, M Schumann, S Kleinert, H Einsele, T Dörner, ...
Arthritis & Rheumatism 63 (5), 1255-1264, 2011
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
J Pieper, J Herrath, S Raghavan, K Muhammad, R van Vollenhoven, ...
BMC immunology 14 (1), 1-9, 2013
NFATc1 controls the cytotoxicity of CD8+ T cells
S Klein-Hessling, K Muhammad, M Klein, T Pusch, R Rudolf, J Flöter, ...
Nature communications 8 (1), 1-15, 2017
NFATc1 induction in peripheral T and B lymphocytes
M Hock, M Vaeth, R Rudolf, AK Patra, DAT Pham, K Muhammad, T Pusch, ...
The Journal of Immunology 190 (5), 2345-2353, 2013
CD27-IgD-memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis
Z Mahmood, K Muhammad, M Schmalzing, P Roll, T Dörner, HP Tony
Arthritis research & therapy 17 (1), 1-11, 2015
Impact of IL-6 receptor inhibition on human memory B cells in vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory …
K Muhammad, P Roll, T Seibold, S Kleinert, H Einsele, T Dörner, HP Tony
Annals of the rheumatic diseases 70 (8), 1507-1510, 2011
Delayed acquisition of somatic hypermutations in repopulated IGD+ CD27+ memory B cell receptors after rituximab treatment
K Muhammad, P Roll, H Einsele, T Dörner, HP Tony
Arthritis & Rheumatism: Official Journal of the American College of …, 2009
Focus: Skin: Current Developments in the Immunology of Psoriasis
F Grän, A Kerstan, E Serfling, M Goebeler, K Muhammad
The Yale journal of biology and medicine 93 (1), 97, 2020
NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells
H Alrefai, K Muhammad, R Rudolf, DAT Pham, S Klein-Hessling, AK Patra, ...
Nature communications 7 (1), 1-13, 2016
Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19
HH Ellah N , Gad S , Muhammad K, Batiha G
Nanomedicine, 2020
NF‐κB factors control the induction of NFATc1 in B lymphocytes
K Muhammad, H Alrefai, R Marienfeld, DAT Pham, K Murti, AK Patra, ...
European journal of immunology 44 (11), 3392-3402, 2014
Architecture and expression of the nfatc1 gene in lymphocytes
R Rudolf, R Busch, AK Patra, K Muhammad, A Avots, JC Andrau, ...
Frontiers in immunology 5, 21, 2014
RF positivity has substantial influence on the peripheral memory B-cell compartment and its modulation by TNF inhibition
P Roll, K Muhammad, M Schumann, S Kleinert, HP Tony
Scandinavian journal of rheumatology 41 (3), 180-185, 2012
Effect of ATG‐F on B‐cell reconstitution after hematopoietic stem cell transplantation
P Roll, K Muhammad, G Stuhler, U Grigoleit, H Einsele, HP Tony
European journal of haematology 95 (6), 514-523, 2015
Long-term repopulation of peripheral B-cell subsets after single and repeated rituximab infusions in patients with rheumatoid arthritis
P Roll, Z Mahmood, K Muhammad, M Feuchtenberger, T Dörner, HP Tony
Clin Exp Rheumatol 33 (3), 347-353, 2015
Multiepitope subunit vaccine design against covid-19 based on the spike protein of sars-cov-2: An in silico analysis
HA Dar, Y Waheed, MH Najmi, S Ismail, HF Hetta, A Ali, K Muhammad
Journal of immunology research 2020, 2020
A threshold level of NFATc1 activity facilitates thymocyte differentiation and opposes notch-driven leukaemia development
S Klein-Hessling, R Rudolf, K Muhammad, KP Knobeloch, MA Maqbool, ...
Nature communications 7 (1), 1-14, 2016
T cells control chemokine secretion by keratinocytes
T Rauschenberger, V Schmitt, M Azeem, S Klein-Hessling, K Murti, F Grän, ...
Frontiers in immunology 10, 1917, 2019
Investigating virological, immunological, and pathological avenues to identify potential targets for developing covid-19 treatment and prevention strategies
Z Mahmood, H Alrefai, HF Hetta, H A Kader, N Munawar, ...
Vaccines 8 (3), 443, 2020
NFATc1 releases BCL6‐dependent repression of CCR2 agonist expression in peritoneal macrophages from Saccharomyces cerevisiae infected mice
R Busch, K Murti, J Liu, AK Patra, K Muhammad, KP Knobeloch, ...
European journal of immunology 46 (3), 634-646, 2016
The system can't perform the operation now. Try again later.
Articles 1–20